PAA 2.78% 18.5¢ pharmaust limited

The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-17

  1. 2,202 Posts.
    lightbulb Created with Sketch. 2697
    By my understanding, FDA feedback is due on the Pre-Investigational New Drug (Pre-IND) meeting ( guaranteed ) by next Tuesday (FDA has committed to provide written responses by 13 February 2024) , and first dose on extension study must be any day.
    2 bits of news , literally, at any moment ... wouldn't you wait for these to drop, at the very least, and sell into that news.

    Go figure ....

 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
18.5¢
Change
0.005(2.78%)
Mkt cap ! $73.24M
Open High Low Value Volume
18.0¢ 19.0¢ 18.0¢ $157.8K 864.0K

Buyers (Bids)

No. Vol. Price($)
6 192000 18.0¢
 

Sellers (Offers)

Price($) Vol. No.
18.5¢ 73740 1
View Market Depth
Last trade - 16.10pm 30/05/2024 (20 minute delay) ?
Last
18.5¢
  Change
0.005 ( 2.78 %)
Open High Low Volume
18.0¢ 19.0¢ 18.0¢ 248618
Last updated 15.45pm 30/05/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.